Priority Date: 15.03.07 (US 20070918171P)

Pyridazinone derivatives useful as glucan synthase inhibitors

  • Application ID: EP12196756
  • Status: EXAMINATION IN PROGRESS

Applicant

Technology company logo small
Technology Company

Attorney

no operation time available
4 offices
Technology Company

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). Merck & Co. Inc. is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 221 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 15.03.2007 - Priority Date (US 20070918171P)
  • 01.05.2013 - Publication A2 (EP2586778)
  • 31.07.2013 - Publication A3 (EP2586778)